SCHEMBL20510013

SCHEMBL20510013

Cc1nnc(C(Cc2c[nH]c3ccccc23)NC(=O)O)o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 4/20 0.57
MAPT P10636 4/20 0.57
GAA P10253 3/20 0.57
POLB P06746 3/20 0.57
NPSR1 Q6W5P4 1/20 0.54
TSHR P16473 2/20 0.53
KDM4E B2RXH2 2/20 0.51
APAF1 O14727 1/20 0.51
RECQL P46063 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
ITGB2 P05107 1/20 0.49
ICAM1 P05362 1/20 0.49
ITGAL P20701 1/20 0.49
ALOX15 P16050 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ALDH1A1 P00352 2/20 0.48
HPGD P15428 1/20 0.48
ACE P12821 2/20 0.48
MEN1 O00255 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20510012 1.00 P4HB (0.57) P4HBMAPTGAAPOLBNPSR1
SCHEMBL30466655 0.87 P4HB (0.76) P4HBMAPTGAAPOLBNPSR1
SCHEMBL29194011 0.87 P4HB (0.76) P4HBMAPTGAAPOLBNPSR1
SCHEMBL6723448 0.84 POLB (0.53) P4HBMAPTGAAPOLBKDM4E
SCHEMBL20509527 0.83 P4HB (0.47) P4HBMAPTGAAPOLBNPSR1
SCHEMBL30267563 0.83 P4HB (0.47) P4HBMAPTGAAPOLBNPSR1
SCHEMBL20509525 0.83 P4HB (0.47) P4HBMAPTGAAPOLBNPSR1
SCHEMBL3784918 0.81 SMN1; SMN2 (0.48) P4HBMAPTGAAPOLBNPSR1
SCHEMBL3789170 0.81 SRC (0.50) P4HBMAPTGAAPOLBTSHR
SCHEMBL7417802 0.80 SMN1; SMN2 (0.51) MAPTPOLBTSHRKDM4EAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3601224-B1 CHEMICAL COMPOUNDS AS ANTIBIOTICS ANTABIO SAS (FR) 2023-07-05 EP disclosed
US-11000511-B2 Chemical compounds as antibiotics ANTABIO SAS (FR) 2021-05-11 US disclosed
US-20200155509-A1 CHEMICAL COMPOUNDS AS ANTIBIOTICS ANTABIO SAS (FR) 2020-05-21 US disclosed
EP-3601224-A1 CHEMICAL COMPOUNDS AS ANTIBIOTICS Antabio SAS (FR) 2020-02-05 EP disclosed
WO-2018172423-A1 CHEMICAL COMPOUNDS AS ANTIBIOTICS ANTABIO SAS (FR) 2018-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155509-A1 CHEMICAL COMPOUNDS AS ANTIBIOTICS MRPL21, CFTR, H1-0 P4HB 1138/4885MAPT 4285/4885GAA 3219/4885
US-11000511-B2 Chemical compounds as antibiotics MRPL21, CFTR, H1-0 P4HB 1138/4885MAPT 4285/4885GAA 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.